Join Profs John Eikelboom, Harry Crijns and Freek Verheugt
Learning Objectives :
This webinar will focus on new treatment strategies in patients with stable ischemic coronary or peripheral arterial disease.
Very recent data of the COMPASS study revealed that NOACs have additional beneficial effects.
These data will be discussed and additional new data of subanalyses of the COMPASS trial will be provided.
Registration will open soon.
Free for everyone
Professor John EikelboomPopulation Health Research InstituteHamilton OntarioCanada
Professor Harry Crijns, FESCMaastricht UMC+Cardiology DepartementMaastrichtNetherlands
Professor Freek VerheugtDepartment of Cardiology Onze Lieve Vrouwe GasthuisNetherlands
This webinar addresses Cardiologists, Neurologists, Vascular Specialists, Vascular Surgeons, Allied Professionals.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
An application has been made to the EACCME® for CME accreditation of this event.
The webinar is available on PC and Tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903 Sophia Antipolis, FR
This programme is supported by Bayer AG in the form of an educational grant.
The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved